Users who used tem:
Free online reference management for clinicians and scientists
Recent "tem" articles
- These articles and links have been posted by Connotea users using the tag "tem".
- To add to this collection, or to start your own library:
Watch a short video (2m 41s)
Create a Connotea Community Page about this tag. 

Number of articles per page:
Nature 401 (6754), 708-12 (14 Oct 1999)
The Journal of Immunology 180 (10), 6777-85 (15 May 2008)
Journal of Clinical Investigation 108 (6), 871 (2001)
Journal of Experimental Medicine 200 (11), 1407 (2004)
The Journal of Experimental Medicine 205 (1), (21 Jan 2008)
Many vaccination strategies and immune cell therapies aim at increasing the numbers of memory T cells reactive to protective antigens. However, the differentiation lineage and therefore the optimal generation conditions of CD4 memory cells remain controversial. Linear and divergent differentiation models have been proposed, suggesting CD4 memory T cell development from naive precursors either with or without an effector-stage intermediate, respectively. Here, we address this question by using newly available techniques for the identification and isolation of effector T cells secreting effector cytokines. In adoptive cell transfers into normal, nonlymphopenic mice, we show that long-lived virus-specific memory T cells can efficiently be generated from purified interferon {gamma}–secreting T helper (Th) type 1 and interleukin (IL)-4– or IL-10–secreting Th2 effectors primed in vitro or in vivo. Importantly, such effector-derived memory T cells were functional in viral challenge infections. They proliferated vigorously, rapidly modulated IL-7 receptor expression, exhibited partial stability and flexibility of their cytokine patterns, and exerted differential effects on virus-induced immunopathology. Thus, cytokine-secreting effectors can evade activation-induced cell death and develop into long-lived functional memory cells. These findings demonstrate the efficiency of linear memory T cell differentiation and encourage the design of vaccines and immune cell therapies based on differentiated effector T cells.
Appl. Phys. Lett. 69 (7), 943-5 (Aug 1996)
J. Appl. Phys. 78 (5), 3138-43 (Sep 1995)
<< Prev 0 Showing entries 1 to 10 of 61 total Next 10 >>


